Detalles de la búsqueda
1.
Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial.
Blood
; 141(16): 1971-1981, 2023 04 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36626583
2.
A real-world observation on thrombopoietic agents for patients with cancer treatment-induced thrombocytopenia in China: A multicenter, cross-sectional study.
Cancer
; 130(S8): 1524-1538, 2024 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38515388
3.
Camrelizumab plus famitinib in previously chemo-immunotherapy treated patients with advanced NSCLC: results from an open-label multicenter phase 2 basket study.
Cancer Immunol Immunother
; 73(7): 124, 2024 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38727837
4.
Pretreatment Pan-Immune-Inflammation Value (PIV) in Predicting Therapeutic Response and Clinical Outcomes of Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma.
Ann Surg Oncol
; 31(1): 272-283, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37838648
5.
Long-term outcomes with HLX01 (HanliKang®), a rituximab biosimilar, in previously untreated patients with diffuse large B-cell lymphoma: 5-year follow-up results of the phase 3 HLX01-NHL03 study.
BMC Cancer
; 24(1): 124, 2024 Jan 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38267866
6.
Rolapitant treats lung cancer by targeting deubiquitinase OTUD3.
Cell Commun Signal
; 22(1): 195, 2024 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38539203
7.
Comparison of Efficacy and Safety of First-Line Treatment Options for Unresectable Stage III Non-Small Cell Lung Cancer: A Retrospective Analysis.
Int J Clin Pract
; 2024: 8585035, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38375028
8.
IMpower210: A phase III study of second-line atezolizumab vs. docetaxel in East Asian patients with non-small cell lung cancer.
Chin J Cancer Res
; 36(2): 103-113, 2024 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38751442
9.
KEYNOTE-033: Randomized phase 3 study of pembrolizumab vs docetaxel in previously treated, PD-L1-positive, advanced NSCLC.
Int J Cancer
; 153(3): 623-634, 2023 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37141294
10.
CLASRP oncogene as a novel target for colorectal cancer.
Funct Integr Genomics
; 23(3): 290, 2023 Sep 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37658940
11.
Pertuzumab, trastuzumab, and docetaxel for Chinese patients with previously untreated HER2-positive locally recurrent or metastatic breast cancer (PUFFIN): final analysis of a phase III, randomized, double-blind, placebo-controlled study.
Breast Cancer Res Treat
; 197(3): 503-513, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36463547
12.
Pamiparib in patients with locally advanced or metastatic HER2-negative breast cancer with germline BRCA mutations: a phase II study.
Breast Cancer Res Treat
; 197(3): 489-501, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36459284
13.
Central nervous system efficacy of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small cell lung cancer: a pooled analysis from two phase 2 studies.
BMC Med
; 21(1): 164, 2023 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37118803
14.
Therapeutic effectiveness of anlotinib combined with etoposide in extensive-stage small-cell lung cancer: a single-arm, phase II trial.
Invest New Drugs
; 41(6): 825-833, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37837490
15.
The role of LncRNAs in tumor immunotherapy.
Cancer Cell Int
; 23(1): 30, 2023 Feb 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36810034
16.
Peripheral blood lymphocytes differentiation patterns in responses / outcomes to immune checkpoint blockade therapies in non-small cell lung cancer: a retrospective study.
BMC Cancer
; 23(1): 83, 2023 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-36698098
17.
The FACT-targeted drug CBL0137 enhances the effects of rituximab to inhibit B-cell non-Hodgkin's lymphoma tumor growth by promoting apoptosis and autophagy.
Cell Commun Signal
; 21(1): 16, 2023 01 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36691066
18.
CircPrimer 2.0: a software for annotating circRNAs and predicting translation potential of circRNAs.
BMC Bioinformatics
; 23(1): 215, 2022 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35668371
19.
MicroRNA-381 in human cancer: Its involvement in tumour biology and clinical applications potential.
J Cell Mol Med
; 26(4): 977-989, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35014178
20.
VLX1570 regulates the proliferation and apoptosis of human lung cancer cells through modulating ER stress and the AKT pathway.
J Cell Mol Med
; 26(1): 108-122, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34854221